Maravai LifeSciences Holdings, Inc. (NASDAQ:NASDAQ:MRVI) Q1 2022 Earnings Conference Call May 05, 2022, 05:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull -.
09.03.2022 - SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor .
CARLSBAD Bicycle donation surprises children Jamie Evans, a Court Appointed Special Advocate volunteer with Voices for Children, her partner Kevin Herde, a Voices for Children supporter, and HM Electronics of Carlsbad, were behind the recent donation of 20 bicycles for youth in foster care.
LELAND — Maravai LifeSciences will relocate one of its companies, Cygnus Technologies, from its home base in Southport to Leland's Waterfront Commercial Park.
Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021 Maravai LifeSciences Holdings LLC San Diego, California, UNITED STATES
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of May.
On May 12, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference at 10:15 a.m. PT.
On May 25, 2021, Carl Hull, Chief Executive Officer will participate in a fireside chat at the UBS Global Healthcare Conference at 2:00 p.m. PT.